A 'cure' for hay fever at last: Pioneering treatment is finally available on the NHS... but sufferers face a postcode lottery. Find out how you can get it
Sam Odell has an allergy to birch tree pollen - the season runs from February to the end of May, meaning months of misery. But thanks to immunotherapy, that's changed. (Source: the Mail online | Health)
Source: the Mail online | Health - April 22, 2024 Category: Consumer Health News Source Type: news
Meditab Integrates Brevium into IMS to Drive Immunotherapy Patient Reactivation
Meditab is pleased to announce the integration of Brevium, the pioneer platform specializing in patient reactivation and retention, into its flagship software solution, IMS. SACRAMENTO, Calif., April 22, 2024 /PRNewswire-PRWeb/ -- Meditab is pleased to announce the integration of Brevium,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 22, 2024 Category: Pharmaceuticals Source Type: news
Has Immunotherapy Found Its Place in Pancreatic Cancer? Has Immunotherapy Found Its Place in Pancreatic Cancer?
A new study suggested that adding nivolumab to neoadjuvant treatment improves outcomes in patients with borderline resectable pancreatic cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Hay fever hacks that doctors and pharmacists use themselves and swear by
From washing their dogs daily to immunotherapy, Natasha Holt discovers how pharmacists and doctors battle pollen and treat their own hayfever symptoms (Source: Daily Express - Health)
Source: Daily Express - Health - April 22, 2024 Category: Consumer Health News Source Type: news
Recommendations Developed to Prepare Patients for Oral Immunotherapy
FRIDAY, April 19, 2024 -- In a research article published online April 8 in the Journal of Allergy and Clinical Immunology, consensus recommendations are presented for preparing and counseling patients and caregivers prior to oral immunotherapy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2024 Category: Pharmaceuticals Source Type: news
Researchers develop a new way to safely boost immune cells to fight cancer
Cancer is the monster of our society. Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped medical progress on developing treatment procedures that are less invasive while still highly effective.
Immunotherapy is on the rise as a possible solution. Immunotherapy involves harnessing the power of the body's immune system to fight against cancer cells. (Source: World Pharma News)
Source: World Pharma News - April 19, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Immunotherapy and Targeted Therapy Regimens for Melanoma Immunotherapy and Targeted Therapy Regimens for Melanoma
Dr Jeffrey Weber discusses recent abstracts focused on melanoma, as presented at ESMO.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
New Consensus Recs for Oral Immunotherapy in Food Allergies
(MedPage Today) -- New consensus recommendations published in the Journal of Allergy and Clinical Immunology offer guidance on preparing patients for the use of oral immunotherapy (OIT) for treating food allergies.
Zahida "Rani" Maskatia, MD... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - April 17, 2024 Category: Allergy & Immunology Source Type: news
Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs
(MedPage Today) -- The use of immune checkpoint inhibitors (ICIs) during pregnancy was not associated with more adverse pregnancy, fetal, or newborn outcomes compared with other anticancer drugs, a cohort study showed.
Adverse pregnancy, fetal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 17, 2024 Category: Hematology Source Type: news
Recommendations Guide Oral Immunotherapy for Food Allergies Recommendations Guide Oral Immunotherapy for Food Allergies
A consensus document emphasizes the control of comorbidities, contraindications to oral immunotherapy, and the importance of informed consent.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 16, 2024 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Advance in immune cell screening uncovers receptors that target prostate cancer
This study validated the ability for nanovials to find T cells, and their receptors, that react to viruses.A second experiment with a different patient applied the technology to a much more challenging problem: rare prostate cancer targets the scientists had identified in previous studies. Importantly, those molecular targets acted to both capture the T cells and cause them to secrete certain molecules that kill target cells. In other experiments, the nanovials also had molecules allowing each to capture more than one type of immune-activating secretion.CNSI at UCLAA closer look at UCLA-developed nanovials, which are hydro...
Source: UCLA Newsroom: Health Sciences - April 15, 2024 Category: Universities & Medical Training Source Type: news
Weighing the Balance: Immunotherapy for Cancer Treatment Weighing the Balance: Immunotherapy for Cancer Treatment
Prof David Kerr discusses immunotherapy for the treatment of cancer and the importance of considering the risks and benefits of treatment.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series
The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce their collaboration with the National Cancer Institute (NCI),... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 12, 2024 Category: Pharmaceuticals Tags: NPT Source Type: news
ImPrint Identifies Treatment for Patients With Breast Cancer ImPrint Identifies Treatment for Patients With Breast Cancer
Data from the ongoing phase 2 trial show that clinicians can use ImPrint, an immune-related biomarker, to identify breast cancer patients who are likely to respond to neoadjuvant immunotherapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Neoadjuvant Chemo-IO Promising in Borderline Resectable Pancreatic Cancer
(MedPage Today) -- SAN DIEGO -- A preoperative combination of chemotherapy and immunotherapy (IO) appeared safe and effective for borderline resectable pancreatic cancer in a small pilot study, a researcher reported here.
In the phase I/II trial... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 11, 2024 Category: Gastroenterology Source Type: news
